Shigeyuki Murono

Prof. Shigeyuki Murono

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Journal of Clinical Oncology
Verified
Journal Article
Open access
NKNAOMI KIYOTA
NAOMI KIYOTA
MTMakoto Tahara
Makoto Tahara
JMJunki Mizusawa
Junki Mizusawa
TKTakeshi Kodaira
Takeshi Kodaira
HFHirofumi Fujii
Hirofumi Fujii
N(Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG)
Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG)
PURPOSE: The standard treatment for postoperative high-risk locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) is chemoradiotherapy with 3-weekly cisplatin (100 mg/m2). However, whether chemoradiotherapy with weekly cisplatin (40 mg/m2) yields comparable efficacy with 3-weekly cisplatin in postoperative high-risk LA-SCCHN is unknown. PATIENTS AND METHODS: In this multi-institutional open-label phase II/III trial, patients with postoperative high-risk LA-SCCHN were randomly assigned to receive either chemoradiotherapy with 3-weekly cisplatin (100 mg/m2) or with weekly cisplatin (40 mg/m2) to confirm the noninferiority of weekly cisplatin. The primary end point of phase II was the proportion of treatment completion, and that of phase III was overall survival. A noninferiority margin of hazard ratio was set at 1.32. RESULTS: Between October 2012 and December 2018, a total of 261 patients were enrolled (3-weekly cisplatin, 132 patients; weekly cisplatin, 129 patients). At the planned third interim analysis in the phase III part, after a median follow-up of 2.2 (interquartile range 1.19-3.56) years, chemoradiotherapy with weekly cisplatin was noninferior to 3-weekly cisplatin in terms of overall survival, with a hazard ratio of 0.69 (99.1% CI, 0.374 to 1.273 [< 1.32], one-sided P for noninferiority = .0027 < .0043). Grade 3 or more neutropenia and infection were less frequent in the weekly arm (3-weekly v weekly, 49% v 35% and 12% v 7%, respectively), as were renal impairment and hearing impairment. No treatment-related death was reported in the 3-weekly arm, and two (1.6%) in the weekly arm. CONCLUSION: Chemoradiotherapy with weekly cisplatin is noninferior to 3-weekly cisplatin for patients with postoperative high-risk LA-SCCHN. These findings suggest that chemoradiotherapy with weekly cisplatin can be a possible treatment option for these patients.

30 July 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
KSKiyoto Shiga
Kiyoto Shiga
Ken-ichi NibuKen-ichi Nibu
Ken-ichi Nibu
YFYasushi Fujimoto
Yasushi Fujimoto
TATakahiro Asakage
Takahiro Asakage
AHAkihiro Homma
Akihiro Homma
RHRyuichi Hayashi
Ryuichi Hayashi

17 January 2017 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
HYHiroshi Yoshida
Hiroshi Yoshida
SMShigeyuki Murono
Shigeyuki Murono
TUTakayoshi Ueno
Takayoshi Ueno
YNYosuke Nakanishi
Yosuke Nakanishi
ATAkira Tsuji
Akira Tsuji
TYTomokazu Yoshizaki
Tomokazu Yoshizaki
Conclusion: The detection of human papillomavirus (HPV)-DNA in oral rinse with auto-nested GP5+/GP6 + PCR is useful as a biomarker of oropharyngeal cancer. Background: This study aimed to determine the usefulness of oral rinse to detect HPV-DNA as a biomarker of HPV-positive oropharyngeal cancer (OPC). Patients and methods: One hundred and ten patients with various head and neck diseases, including 19 patients with OPC, were enrolled. Oral rinse and tonsillar swab were collected, and auto-nested GP5+/GP6 + PCR for HPV-DNA was performed. For oropharyngeal cancer, p16 immunostaining was also conducted. Results: The rate of HPV-DNA detection in both oral rinse and tonsillar swab was significantly higher in OPC compared with non-OPC upper respiratory tract cancer and non-cancer diseases. HPV-DNA was detected in oral rinse in nine out of 12 p16-positive OPC cases, while none of the p16-negative OPC cases demonstrated detectable HPV-DNA. All p16-positive cases were also positive for HPV-DNA in tumor tissue. Based on p16 immunostaining, the sensitivity and specificity of HPV-DNA detection in oral rinse were 75% and 100%, respectively. Among eight of nine evaluable OPC cases positive for HPV-DNA in oral rinse at diagnosis, HPV-DNA was undetectable in oral rinse in seven cases after treatment.

17 May 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
MIMitsuyoshi Imaizumi
Mitsuyoshi Imaizumi
TSToshihiko Suzuki
Toshihiko Suzuki
TMTakashi Matsuzuka
Takashi Matsuzuka
SMShigeyuki Murono
Shigeyuki Murono
KOKoichi Omori
Koichi Omori

Verified
Journal Article
Open access
PDF file
SYSusumu Yoshie
Susumu Yoshie
SMShigeyuki Murono
Shigeyuki Murono
AHAkihiro Hazama
Akihiro Hazama
Airway remodeling caused by asthma is characterized by structural changes of subepithelial fibrosis, goblet cell metaplasia, submucosal gland hyperplasia, smooth muscle cell hyperplasia, and angiogenesis, leading to symptoms such as dyspnea, which cause marked quality of life deterioration. In particular, fibrosis exacerbated by asthma progression is reportedly mediated by epithelial-mesenchymal transition (EMT). It is well known that the molecular mechanism of EMT in fibrosis of asthmatic airway remodeling is closely associated with several signaling pathways, including the TGF-β1/Smad, TGF-β1/non-Smad, and Wnt/β-catenin signaling pathways. However, the molecular mechanism of EMT in fibrosis of asthmatic airway remodeling has not yet been fully clarified. Given that Cl− transport through Cl− channels causes passive water flow and consequent changes in cell volume, these channels may be considered to play a key role in EMT, which is characterized by significant morphological changes. In the present article, we highlight how EMT, which causes fibrosis and carcinogenesis in various tissues, is strongly associated with activation or inactivation of Cl− channels and discuss whether Cl− channels can lead to elucidation of the molecular mechanism of EMT in fibrosis of asthmatic airway remodeling.

29 January 2021 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
SMShigeyuki Murono
Shigeyuki Murono
KKKei Kakinouchi
Kei Kakinouchi
MIMitsuyoshi Imaizumi
Mitsuyoshi Imaizumi
MNMika Nomoto
Mika Nomoto
MSMasahiro Suzuki
Masahiro Suzuki
Cricotracheostomy, a modified procedure to open the airway with partial cricoid cartilage resection, was recently reported to be useful in selected cases. To examine decannulation outcomes in patie... 背景:环气管切开术, 即部分切除环状软骨, 是一种改良的开放气道的手术。据最近报道, 该手术在某些病例中是有用的。 目的:比较环气管切开术与传统气管切开术的拔管效果。 材料和方法:收集并分析2016年至2019年间连续127例接受传统气管切开术或环气管切开术的成人患者的数据, 以及随后拔管并关闭呼吸孔的情况。 结果:传统气管切开94例, 环气管切开33例。选择环气管切开术最常见的原因是生理性...